Stable prevalence of transmitted drug ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-b subtypes in antiretroviral-naive chronically hiv-infected patients in 2015/2016 in france
Auteur(s) :
Assoumou, Lambert [Auteur]
Bocket, Laurence [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Pallier, Coralie [Auteur]
Grude, Maxime [Auteur]
Ait-Namane, Rachid [Auteur]
Izopet, Jacques [Auteur]
Raymond, Stephanie [Auteur]
Charpentier, Charlotte [Auteur]
Infection, Anti-microbiens, Modélisation, Evolution [IAME (UMR_S_1137 / U1137)]
Visseaux, Benoit [Auteur]
Wirden, Marc [Auteur]
Trabaud, Mary-Anne [Auteur]
Le Guillou-Guillemette, Helene [Auteur]
Allaoui, Chakib [Auteur]
Henquell, Cecile [Auteur]
Krivine, Anne [Auteur]
Dos Santos, Georges [Auteur]
Delamare, Catherine [Auteur]
Bouvier-Alias, Magali [Auteur]
Montes, Brigitte [Auteur]
Ferre, Virginie [Auteur]
De Monte, Anne [Auteur]
Signori-Schmuck, Anne [Auteur]
Maillard, Anne [Auteur]
Morand-Joubert, Laurence [Auteur]
Tumiotto, Camille [Auteur]
Fafi-Kremer, Samira [Auteur]
Amiel, Corinne [Auteur]
Barin, Francis [Auteur]
Marque-Juillet, Stephanie [Auteur]
Courdavault, Laurence [Auteur]
Vallet, Sophie [Auteur]
Beby-Defaux, Agnes [Auteur]
De Rougemont, Alexis [Auteur]
Fenaux, Honorine [Auteur]
Avettand-Fenoel, Véronique [Auteur]
Allardet-Servent, Annick [Auteur]
Plantier, Jean-Christophe [Auteur]
Peytavin, Gilles [Auteur]
Calvez, Vincent [Auteur]
Chaix, Marie-Laure [Auteur]
Descamps, Diane [Auteur]
Bocket, Laurence [Auteur]
Laboratoire de Virologie - ULR 3610 [Laboratoire de Virologie]
Pallier, Coralie [Auteur]
Grude, Maxime [Auteur]
Ait-Namane, Rachid [Auteur]
Izopet, Jacques [Auteur]
Raymond, Stephanie [Auteur]
Charpentier, Charlotte [Auteur]
Infection, Anti-microbiens, Modélisation, Evolution [IAME (UMR_S_1137 / U1137)]
Visseaux, Benoit [Auteur]
Wirden, Marc [Auteur]
Trabaud, Mary-Anne [Auteur]
Le Guillou-Guillemette, Helene [Auteur]
Allaoui, Chakib [Auteur]
Henquell, Cecile [Auteur]
Krivine, Anne [Auteur]
Dos Santos, Georges [Auteur]
Delamare, Catherine [Auteur]
Bouvier-Alias, Magali [Auteur]
Montes, Brigitte [Auteur]
Ferre, Virginie [Auteur]
De Monte, Anne [Auteur]
Signori-Schmuck, Anne [Auteur]
Maillard, Anne [Auteur]
Morand-Joubert, Laurence [Auteur]
Tumiotto, Camille [Auteur]
Fafi-Kremer, Samira [Auteur]
Amiel, Corinne [Auteur]
Barin, Francis [Auteur]
Marque-Juillet, Stephanie [Auteur]
Courdavault, Laurence [Auteur]
Vallet, Sophie [Auteur]
Beby-Defaux, Agnes [Auteur]
De Rougemont, Alexis [Auteur]
Fenaux, Honorine [Auteur]
Avettand-Fenoel, Véronique [Auteur]
Allardet-Servent, Annick [Auteur]
Plantier, Jean-Christophe [Auteur]
Peytavin, Gilles [Auteur]
Calvez, Vincent [Auteur]
Chaix, Marie-Laure [Auteur]
Descamps, Diane [Auteur]
Titre de la revue :
The Journal of antimicrobial chemotherapy
Nom court de la revue :
J. Antimicrob. Chemother.
Numéro :
74
Pagination :
1417-1424
Date de publication :
2019-02-11
ISSN :
1460-2091
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
OBJECTIVE: We estimated the prevalence of transmitted-drug-resistance-associated mutations (TDRAMs) in antiretroviral-naive chronically HIV-1-infected patients.
METHODS: TDRAMs were sought in samples from 660 diagnosed ...
Lire la suite >OBJECTIVE: We estimated the prevalence of transmitted-drug-resistance-associated mutations (TDRAMs) in antiretroviral-naive chronically HIV-1-infected patients. METHODS: TDRAMs were sought in samples from 660 diagnosed HIV-1-infected individuals in 2015/2016 in 33 HIV clinical centres. Weighted analyses, considering the number of patients followed in each centre, were used to derive representative estimates of the percentage of individuals with TDRAMs. Results were compared with those of the 2010/2011 survey (n = 661) using the same methodology. RESULTS: At inclusion, median CD4 cell counts and plasma HIV-1 RNA were 394 and 350/mm3 (P = 0.056) and 4.6 and 4.6 log10 copies/mL (P = 0.360) in the 2010/2011 survey and the 2015/2016 survey, respectively. The frequency of non-B subtypes increased from 42.9% in 2010/2011 to 54.8% in 2015/2016 (P < 0.001), including 23.4% and 30.6% of CRF02_AG (P = 0.004). The prevalence of virus with protease or reverse-transcriptase TDRAMs was 9.0% (95% CI = 6.8-11.2) in 2010/2011 and 10.8% (95% CI = 8.4-13.2) in 2015/2016 (P = 0.269). No significant increase was observed in integrase inhibitor TDRAMs (6.7% versus 9.2%, P = 0.146). Multivariable analysis showed that men infected with the B subtype were the group with the highest risk of being infected with a resistant virus compared with others (adjusted OR = 2.2, 95% CI = 1.3-3.9). CONCLUSIONS: In France in 2015/2016, the overall prevalence of TDRAMs was 10.8% and stable compared with 9.0% in the 2010/2011 survey. Non-B subtypes dramatically increased after 2010. Men infected with B subtype were the group with the highest risk of being infected with a resistant virus, highlighting the need to re-emphasize safe sex messages.Lire moins >
Lire la suite >OBJECTIVE: We estimated the prevalence of transmitted-drug-resistance-associated mutations (TDRAMs) in antiretroviral-naive chronically HIV-1-infected patients. METHODS: TDRAMs were sought in samples from 660 diagnosed HIV-1-infected individuals in 2015/2016 in 33 HIV clinical centres. Weighted analyses, considering the number of patients followed in each centre, were used to derive representative estimates of the percentage of individuals with TDRAMs. Results were compared with those of the 2010/2011 survey (n = 661) using the same methodology. RESULTS: At inclusion, median CD4 cell counts and plasma HIV-1 RNA were 394 and 350/mm3 (P = 0.056) and 4.6 and 4.6 log10 copies/mL (P = 0.360) in the 2010/2011 survey and the 2015/2016 survey, respectively. The frequency of non-B subtypes increased from 42.9% in 2010/2011 to 54.8% in 2015/2016 (P < 0.001), including 23.4% and 30.6% of CRF02_AG (P = 0.004). The prevalence of virus with protease or reverse-transcriptase TDRAMs was 9.0% (95% CI = 6.8-11.2) in 2010/2011 and 10.8% (95% CI = 8.4-13.2) in 2015/2016 (P = 0.269). No significant increase was observed in integrase inhibitor TDRAMs (6.7% versus 9.2%, P = 0.146). Multivariable analysis showed that men infected with the B subtype were the group with the highest risk of being infected with a resistant virus compared with others (adjusted OR = 2.2, 95% CI = 1.3-3.9). CONCLUSIONS: In France in 2015/2016, the overall prevalence of TDRAMs was 10.8% and stable compared with 9.0% in the 2010/2011 survey. Non-B subtypes dramatically increased after 2010. Men infected with B subtype were the group with the highest risk of being infected with a resistant virus, highlighting the need to re-emphasize safe sex messages.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Université de Lille
Université de Lille
Collections :
Date de dépôt :
2019-12-09T16:50:52Z
2024-02-23T09:52:27Z
2024-02-23T09:52:27Z